Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Control Release ; 296: 1-13, 2019 02 28.
Article in English | MEDLINE | ID: mdl-30615983

ABSTRACT

Acidic pH in the tumor microenvironment is associated with cancer metabolism and creates a physiological barrier that prevents from drugs to penetrate cells. Specifically, ionizable weak-base drugs, such as doxorubicin, freely permeate membranes in their uncharged form, however, in the acidic tumor microenvironment these drugs become charged and their cellular permeability is retarded. In this study, 100-nm liposomes loaded with sodium bicarbonate were used as adjuvants to elevate the tumor pH. Combined treatment of triple-negative breast cancer cells (4T1) with doxorubicin and sodium-bicarbonate enhanced drug uptake and increased its anti-cancer activity. In vivo, mice bearing orthotropic 4T1 breast cancer tumors were administered either liposomal or free bicarbonate intravenously. 3.7 ±â€¯0.3% of the injected liposomal dose was detected in the tumor after twenty-four hours, compared to 0.17% ±â€¯0.04% in the group injected free non-liposomal bicarbonate, a 21-fold increase. Analyzing nanoparticle biodistribution within the tumor tissue revealed that 93% of the PEGylated liposomes accumulated in the extracellular matrix, while 7% were detected intracellularly. Mice administered bicarbonate-loaded liposomes reached an intra-tumor pH value of 7.38 ±â€¯0.04. Treating tumors with liposomal bicarbonate combined with a sub-therapeutic dose of doxorubicin achieved an improved therapeutic outcome, compared to mice treated with doxorubicin or bicarbonate alone. Interestingly, analysis of the tumor microenvironment demonstrated an increase in immune cell' population (T-cell, B-cell and macrophages) in tumors treated with liposomal bicarbonate. This study demonstrates that targeting metabolic adjuvants with nanoparticles to the tumor microenvironment can enhance anticancer drug activity and improve treatment.


Subject(s)
Antineoplastic Agents/administration & dosage , Doxorubicin/administration & dosage , Nanoparticles/administration & dosage , Neoplasms , Sodium Bicarbonate/administration & dosage , Animals , Antineoplastic Agents/pharmacokinetics , Biological Transport/drug effects , Cell Count , Cell Line, Tumor , Cell Survival/drug effects , Doxorubicin/pharmacokinetics , Female , Humans , Hydrogen-Ion Concentration , Liposomes , Mice, Inbred BALB C , Neoplasms/chemistry , Neoplasms/drug therapy , Neoplasms/immunology , Neoplasms/metabolism , Sodium Bicarbonate/pharmacokinetics , Tumor Microenvironment/drug effects , Tumor Microenvironment/immunology
2.
J Vis Exp ; (106): e53370, 2015 Dec 18.
Article in English | MEDLINE | ID: mdl-26709460

ABSTRACT

Lineage tracing experiments define the origin, fate and behavior of cells in a specific tissue or organism. This technique has been successfully applied for many decades, revealing seminal findings in developmental biology. More recently, it was adopted by stem cell biologists to identify and track different stem cell populations with minimal experimental intervention. The recent developments in mouse genetics, the availability of a large number of mouse strains, and the advancements in fluorescent microscopy allow the straightforward design of powerful lineage tracing systems for various tissues with basic expertise, using commercially available tools. We have recently taken advantage of this powerful methodology to explore the origin and fate of stem cells at the ocular surface using R26R-Confetti mouse. This model offers a multi-color genetic system, for the expression of 4 fluorescent genes in a random manner. Here we describe the principles of this methodology and provide an adaptable protocol for designing lineage tracing experiments; specifically for the corneal epithelium as well as for other tissues.


Subject(s)
Cornea/cytology , Luminescent Proteins/analysis , Stem Cells/cytology , Alleles , Animals , Cell Lineage , Genes, Reporter , Integrases/biosynthesis , Integrases/genetics , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice , Mice, Transgenic , Microscopy, Confocal/methods , Spectrometry, Fluorescence/methods
3.
J Cell Biol ; 209(6): 829-42, 2015 Jun 22.
Article in English | MEDLINE | ID: mdl-26101218

ABSTRACT

Association of messenger RNAs with large complexes such as processing bodies (PBs) plays a pivotal role in regulating their translation and decay. Little is known about other possible functions of these assemblies. Exposure of haploid yeast cells, carrying mating type "a," to "α pheromone" stimulates polarized growth resulting in a "shmoo" projection; it also induces synthesis of "a pheromone," encoded by MFA2. In this paper, we show that, in response to α pheromone, MFA2 mRNA is assembled with two types of granules; both contain some canonical PB proteins, yet they differ in size, localization, motility, and sensitivity to cycloheximide. Remarkably, one type is involved in mRNA transport to the tip of the shmoo, whereas the other-in local translation in the shmoo. Normal assembly of these granules is critical for their movement, localization, and for mating. Thus, MFA2 mRNAs are transported to the shmoo tip, in complex with PB-like particles, where they are locally translated.


Subject(s)
Cell Surface Extensions/metabolism , Lipoproteins/biosynthesis , Pheromones/biosynthesis , RNA, Messenger/metabolism , Ribonucleoproteins/metabolism , Saccharomyces cerevisiae Proteins/biosynthesis , Saccharomyces cerevisiae/metabolism , Biological Transport , Cell Membrane Structures/metabolism , Cytoplasmic Granules/genetics , Cytoplasmic Granules/metabolism , Lipoproteins/genetics , Pheromones/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae Proteins/genetics
4.
Atherosclerosis ; 239(1): 232-9, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25618031

ABSTRACT

OBJECTIVE: Homozygosity for a 1.7 kb intragenic duplication of the Haptoglobin (Hp) gene (Hp 2-2 genotype), present in 36% of the population, has been associated with a 2-3 fold increased incidence of atherothrombosis in individuals with Diabetes (DM) in 10 longitudinal studies compared to DM individuals not homozygous for this duplication (Hp 1-1/2-1). The increased CVD risk associated with the Hp 2-2 genotype has been shown to be prevented with vitamin E supplementation in man. We sought to determine if there was an interaction between the Hp genotype and vitamin E on atherosclerotic plaque growth and stability in a transgenic model of the Hp polymorphism. METHODS AND RESULTS: Brachiocephalic artery atherosclerotic plaque volume was serially assessed by high resolution ultrasound in 28 Hp 1-1 and 26 Hp 2-2 mice in a C57Bl/6 ApoE(-/-) background. Hp 2-2 mice had more rapid plaque growth and an increased incidence of plaque hemorrhage and rupture. Vitamin E significantly reduced plaque growth in Hp 2-2 but not in Hp 1-1 mice with a significant pharmacogenomic interaction between the Hp genotype and vitamin E on plaque growth. CONCLUSIONS: These results may help explain why vitamin E supplementation in man can prevent CVD in Hp 2-2 DM but not in non Hp 2-2 DM individuals.


Subject(s)
Genotype , Haptoglobins/genetics , Plaque, Atherosclerotic/genetics , Vitamin E/metabolism , Alleles , Animals , Antioxidants/metabolism , Apolipoproteins E/genetics , Brachiocephalic Trunk/pathology , Dietary Supplements , Disease Progression , Homozygote , Mice , Mice, Inbred C57BL , Mice, Transgenic , Oxygen/chemistry
5.
Methods Mol Biol ; 1265: 425-39, 2015.
Article in English | MEDLINE | ID: mdl-25634294

ABSTRACT

Mitochondria, similar to living cells and organelles, have negative membrane potential and can therefore accumulate permeable lipophilic cations. Those cations which exhibit fluorescence activity after accumulation into energized systems are widely used to decipher changes in membrane potential by imaging techniques. Here we describe the use of the lipophilic cation 5,5',6,6'tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodide (JC-1), which alters reversibly its color from green (J-monomer, at its low concentration in the cytosol) to red (J-aggregates, at its high concentration in active mitochondria) with increasing mitochondrial membrane potential (Δψm). We show that in addition to changes in Δψm, this specific dye can be used to follow alterations in mitochondrial distribution and mitochondrial network connectivity. We suggest that JC-1 is a preferable probe to compare between treatment groups, as the ratio of green to red fluorescence intensities is used for analysis. This ratio depends only on the mitochondrial membrane potential and not on other mitochondrial dependent or independent factors. We demonstrate various applications of JC-1 staining to study mitochondrial abnormalities in different cell types derived from schizophrenia patients and healthy subjects.


Subject(s)
Microscopy, Fluorescence , Mitochondria/metabolism , Molecular Imaging/methods , Schizophrenia/metabolism , Biological Transport , Cell Line , Humans , Image Processing, Computer-Assisted , Membrane Potential, Mitochondrial , Microscopy, Fluorescence/methods
6.
Carcinogenesis ; 34(10): 2370-9, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23828904

ABSTRACT

Lysyl oxidase-like 2 (LOXL2), a secreted enzyme that catalyzes the cross-linking of collagen, plays an essential role in developmental angiogenesis. We found that administration of the LOXL2-neutralizing antibody AB0023 inhibited bFGF-induced angiogenesis in Matrigel plug assays and suppressed recruitment of angiogenesis promoting bone marrow cells. Small hairpin RNA-mediated inhibition of LOXL2 expression or inhibition of LOXL2 using AB0023 reduced the migration and network-forming ability of endothelial cells, suggesting that the inhibition of angiogenesis results from a direct effect on endothelial cells. To examine the effects of AB0023 on tumour angiogenesis, AB0023 was administered to mice bearing tumours derived from SKOV-3 ovarian carcinoma or Lewis lung carcinoma (LLC) cells. AB0023 treatment significantly reduced the microvascular density in these tumours but did not inhibit tumour growth. However, treatment of mice bearing SKOV-3-derived tumours with AB0023 also promoted increased coverage of tumour vessels with pericytes and reduced tumour hypoxia, providing evidence that anti-LOXL2 therapy results in the normalization of tumour blood vessels. In agreement with these data, treatment of mice bearing LLC-derived tumours with AB0023 improved the perfusion of the tumour-associated vessels as determined by ultrasonography. Improved perfusion and normalization of tumour vessels after treatment with anti-angiogenic agents were previously found to improve the delivery of chemotherapeutic agents into tumours and to result in an enhancement of chemotherapeutic efficiency. Indeed, treatment with AB0023 significantly enhanced the anti-tumourigenic effects of taxol. Our results suggest that inhibition of LOXL2 may prove beneficial for the treatment of angiogenic tumours.


Subject(s)
Amino Acid Oxidoreductases/genetics , Neoplasms/blood supply , Neoplasms/genetics , Neovascularization, Pathologic/genetics , Amino Acid Oxidoreductases/antagonists & inhibitors , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/pharmacology , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Neutralizing/pharmacology , Cell Line , Cell Movement/drug effects , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Female , Fibroblast Growth Factor 2/pharmacology , Humans , Mice , Neoplasms/drug therapy , Neovascularization, Pathologic/drug therapy
7.
PLoS One ; 3(6): e2319, 2008 Jun 11.
Article in English | MEDLINE | ID: mdl-18545691

ABSTRACT

Heparanase is a heparan sulfate (HS) degrading endoglycosidase participating in extracellular matrix degradation and remodeling. Apart of its well characterized enzymatic activity, heparanase was noted to exert also enzymatic-independent functions. Non-enzymatic activities of heparanase include enhanced adhesion of tumor-derived cells and primary T-cells. Attempting to identify functional domains of heparanase that would serve as targets for drug development, we have identified heparin binding domains of heparanase. A corresponding peptide (residues Lys(158)-Asp(171), termed KKDC) was demonstrated to physically associate with heparin and HS, and to inhibit heparanase enzymatic activity. We hypothesized that the pro-adhesive properties of heparanase are mediated by its interaction with cell surface HS proteoglycans, and utilized the KKDC peptide to examine this possibility. We provide evidence that the KKDC peptide interacts with cell membrane HS, resulting in clustering of syndecan-1 and syndecan-4. We applied classical analysis of cell morphology, fluorescent and time-lapse microscopy and demonstrated that the KKDC peptide efficiently stimulates the adhesion and spreading of various cell types, mediated by PKC, Src, and the small GTPase Rac1. These results support, and further substantiate the notion that heparanase function is not limited to its enzymatic activity.


Subject(s)
Cell Adhesion/physiology , Cell Movement/physiology , Glucuronidase/physiology , Heparan Sulfate Proteoglycans/metabolism , Amino Acid Sequence , Cell Line, Tumor , Cell Membrane/metabolism , Glucuronidase/metabolism , Humans , Immunohistochemistry , Oligopeptides/chemistry , Oligopeptides/metabolism , Protein Binding , Syndecans/metabolism
8.
Pediatr Surg Int ; 24(1): 21-8, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17985142

ABSTRACT

Recent evidence suggests that transforming growth factor alpha (TGF-alpha) enhances enterocyte proliferation and stimulates intestinal adaptation after massive bowel resection. In the present study, we evaluated the effects of TGF-alpha on enterocyte turnover and correlated it with epidermal-growth factor (EGF) receptor expression along the villus-crypt axis in a rat model of short bowel syndrome (SBS). Male rats were divided into three groups, sham rats underwent bowel transection (group A); SBS rats underwent a 75% bowel resection (group B); and SBS/TGF-alpha rats underwent bowel resection and were treated with TGF-alpha (75 microg/kg) (group C) from the seventh postoperative day. Parameters of intestinal adaptation, enterocyte proliferation and apoptosis were determined on day 15. Villus tips, lateral villi and crypts were separated using laser capture microdissection. EGF receptor expression for each compartment was assessed by quantitative real-time PCR (Taqman). Statistical analysis was performed using one-way ANOVA test, with P < 0.05 considered statistically significant. Treatment with TGF-alpha resulted in a significant increase in all parameters of intestinal adaptation. EGF receptor expression in crypts significantly increased in SBS rats (vs sham rats) (0.035 +/- 0.013 vs 0.010 +/- 0.002 Log ng Total RNA/18 s) and was accompanied by a significant increase in enterocyte proliferation (169 +/- 8 vs 138 +/- 5 BrdU positive cells/per 10 crypts, P < 0.05) and decreased apoptosis following TGF-alpha administration (group C). A significant decrease in EGF receptor expression at the tip of the villus (0.005 +/- 0.002 vs 0.029 +/- 0.014 Log ng Total RNA/18 s) and in the lateral villus (0.003 +/- 0.001 vs 0.028 +/- 0.006 Log ng Total RNA/18 s) in SBS (group B) rats (vs sham, group A) was accompanied by increased cell apoptosis in these compartments following treatment with TGF-alpha (group C). In a rat model of SBS, TGF-alpha increased enterocyte proliferation and stimulated intestinal adaptation. The effect of TGF-alpha on enterocyte turnover is correlated with EGF receptor expression along the villus-crypt axis.


Subject(s)
Enterocytes/pathology , ErbB Receptors/genetics , Gene Expression , RNA, Messenger/genetics , Short Bowel Syndrome/pathology , Transforming Growth Factor alpha/therapeutic use , Animals , Apoptosis , Caspase 3/metabolism , Cell Proliferation/drug effects , Disease Models, Animal , Enterocytes/drug effects , Enterocytes/metabolism , ErbB Receptors/biosynthesis , Follow-Up Studies , Immunohistochemistry , Male , Microscopy, Confocal , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Short Bowel Syndrome/drug therapy , Short Bowel Syndrome/metabolism
9.
Hum Reprod ; 19(3): 670-5, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14998969

ABSTRACT

BACKGROUND: IVF occasionally produces aneuploid zygotes with one or three pronuclei (PN). Routinely, these zygotes are discarded. The aim of this work was to establish human embryonic stem cell (hESC) lines from blastocysts resulting from abnormal fertilization. METHODS: Abnormally fertilized zygotes were cultured to the blastocyst stage and, following zona pellucida digestion, zona-free blastocysts were placed on a mouse feeder layer. Culture of hESCs was carried out as described earlier. RESULTS: Six out of the nine developing blastocysts attached to the feeder layer. One hESC line, originating from a mononuclear zygote following ICSI, was successfully derived. This line displayed typical phenotype and embryonic surface markers, and exhibited the potential to develop into all three embryonic germ layers both in vitro (by embryoid body formation) and in vivo (teratoma generation). Genetic examination revealed normal diploid karyotype and heterozygotic appearance for metachromatic leukodystrophy (MLD). CONCLUSION: This method, which requires neither immuno nor mechanical removal of the trophectoderm, may facilitate the derivation of hESC lines in general, and those from abnormal embryos in particular. Furthermore, it is shown that aneuploid zygotes can be used as a source for normal hESC derivation and hold the potential to generate aneuploid hESC lines for research purposes.


Subject(s)
Cell Line , Cell Nucleus/ultrastructure , Stem Cells/cytology , Zygote/cytology , Animals , Cells, Cultured , Diploidy , Fertilization in Vitro , Heterozygote , Hindlimb , Humans , In Vitro Techniques , Karyotyping , Leukodystrophy, Metachromatic/genetics , Mice , Muscle Neoplasms/etiology , Muscle Neoplasms/pathology , Stem Cell Transplantation , Stem Cells/physiology , Teratoma/etiology , Teratoma/pathology , Transplantation, Heterologous , Zygote/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...